THRM Earnings

THRM reported its FY2025Q4 earnings on 2026-02-18, showcasing a revenue of 0.00 against an estimate of 363.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.65 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following THRM's FY2025Q4 earnings announcement on 2026-02-18, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, THRM's stock price tends to shift by an average of +0.22% in the 10 days leading up to earnings and -1.04% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate THRM’s annual revenue to reach 363.00M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between THRM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, THRM's stock price typically moves by +0.22% in the 10 days before its earnings and -1.04% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.00 and revenue of 363.00M.

The earnings call summary highlights several positive aspects, such as increased revenue guidance, strong automotive revenue growth, and strategic market expansions. While there are challenges like higher material costs and medical revenue decline, the company’s optimistic guidance, strategic partnerships, and market expansion efforts outweigh these concerns. The Q&A section reinforces positive sentiment with innovative product developments and strategic market entries. Given the company's market cap, these factors suggest a positive stock price movement of 2% to 8% over the next two weeks.